Can Dermatologists Treat Chronic Herpes Zoster (Shingles)?
Yes, dermatologists can and do treat chronic herpes zoster, as it is fundamentally a cutaneous viral infection that falls squarely within dermatologic expertise. However, the management approach depends critically on the patient's immune status and whether complications have developed.
Clinical Context and Dermatologic Role
Herpes zoster is explicitly recognized as a skin and soft tissue infection in major infectious disease guidelines 1. The 2014 IDSA guidelines specifically address VZV as "one of the 2 most frequent herpesviruses to cause cutaneous infection" and provide detailed management protocols 1. Dermatologists routinely diagnose and manage this condition based on clinical presentation, with the characteristic unilateral vesicular eruption and dermatomal distribution 1, 2, 3.
Treatment Approach by Patient Population
Immunocompetent Patients with Chronic/Prolonged Lesions
For otherwise healthy patients whose lesions persist beyond the typical 2-week course:
- Oral antiviral therapy (acyclovir, famciclovir, or valacyclovir) is appropriate for mild to moderate cases 1
- Treatment should continue until lesions fully crust over
- Dermatologists can manage this independently, including pain management with analgesics and neuroactive agents like amitriptyline 4, 5
Immunocompromised Patients with Chronic Ulcerations
This is where management becomes more complex and requires heightened vigilance:
Without adequate treatment, immunocompromised patients develop chronic ulcerations with persistent viral replication complicated by secondary bacterial and fungal superinfections 1. In these cases:
- High-dose IV acyclovir remains the treatment of choice 1, 6
- Oral therapy should only be used for mild cases or to complete therapy after clinical response to IV treatment 1
- Dermatologists should maintain close outpatient follow-up or coordinate inpatient care 7
- Skin biopsy may be needed to rule out superinfection or antiviral resistance 1
Key Clinical Pitfalls
Critical warning: Among immunocompromised hosts, skin lesions may continue developing for 7-14 days and heal much more slowly than the typical course 1. These chronic ulcerative lesions rarely include a vesicular component, making clinical diagnosis more difficult 6. If lesions develop in patients already taking oral antivirals, antiviral resistance must be investigated 1.
When to Involve Other Specialists
Dermatologists should coordinate care with:
- Infectious disease specialists: For disseminated disease, suspected antiviral resistance, or profoundly immunosuppressed patients
- Pain specialists: For postherpetic neuralgia or severe acute pain unresponsive to standard analgesics 4, 5
- Ophthalmology: For any ophthalmic involvement (zoster ophthalmicus) 4
- Neurology: For central nervous system complications
Diagnostic Confirmation
While diagnosis is primarily clinical 2, 3, laboratory confirmation via PCR is the gold standard when needed, particularly in immunocompromised patients with atypical presentations 1, 4. Direct viral identification in cell cultures and detection of IgM/IgA anti-VZV antibodies may be helpful in immunocompromised patients 4.
Bottom Line
Dermatologists are well-positioned to treat chronic shingles, particularly in immunocompetent patients. The specialty's expertise in cutaneous viral infections, familiarity with antiviral regimens, and ability to manage local wound care and secondary infections makes dermatology an appropriate choice. However, immunocompromised patients with chronic ulcerations require more aggressive systemic therapy and often benefit from multidisciplinary management 1, 7.